Information

Guide to using Lepore during the growth period:...

"Will this sleeping pill be addictive?" "After taking Lebrexan for a month, will my insomnia become worse if I suddenly stop taking it?" As a new type of orexin receptor...

Beware! A complete guide to the risks of drug i...

As the clinical application of GLP-1 drugs in the field of glucose reduction and weight loss continues to heat up, the new generation of dual receptor agonist Tirzepatide has attracted...

Traditional hypoglycemic drugs have poor effect...

🔍 Three major challenges of traditional hypoglycemic drugs A 2023 survey on diabetes diagnosis and treatment in China showed that among patients using traditional hypoglycemic drugs: ● 42% face the...

In-depth analysis of oral and injectable semagl...

With the continuous development of diabetes treatment, the launch of semaglutide oral tablets in 2025 will bring new treatment options to patients. This article will comprehensively compare the characteristics of...

Lebrexan vs. traditional sleeping pills: 5 majo...

"Another sleepless night..." This may be the common voice of countless insomnia patients. According to statistics, about 30% of the world's population suffers from insomnia to varying degrees, and nearly...

The three core advantages of tesiparatide: scie...

According to the global diabetes drug sales data in 2023, Tirzepatide has occupied 35% of the GLP-1 receptor agonist market share in just 18 months after its launch, while the...